Related Experiment Video
Updated: Aug 29, 2026

The Bovine Lung in Biomedical Research: Visually Guided Bronchoscopy, Intrabronchial Inoculation and In Vivo Sampling Techniques
Published on: July 3, 2014
The chlamydial pneumonias
1Infectious Disease Division, Winthrop-University Hospital, Mineola, New York 11501, USA.
Abstract:
Chlamydia psittaci and Chlamydia pneumoniae are important causes of community-acquired pneumonias. Less commonly, C. trachomatis may cause pneumonia in adult immunocompromised hosts but more commonly is responsible for pneumonia in neonates. C. psittaci is the cause of psittacosis and is the only chlamydial zoonotic atypical pneumonia. C. pneumoniae is being increasingly recognized as the cause of up to 10% of community-acquired pneumonias. C. pneumoniae pneumonia has a clinical presentation like Mycoplasma pneumoniae pneumonia. C. pneumoniae is also responsible for a variety of other respiratory tract infections, e.g., sinusitis, bronchitis, otitis, pharyngitis and laryngitis. C. pneumoniae, like M. pneumoniae, may result in permanent airway disease, e.g., asthma, following infection. All chlamydia are sensitive to doxycycline. Macrolides are highly active against C. trachomatis, and in spite of in vitro susceptibility, are relatively inactive in vivo against C. psittaci and C. pneumoniae. Fluoroquinolones are also active against chlamydia. Doxycycline remains the preferred antibiotic to treat all chlamydial infections in nonpregnant adults.
Insights
Chlamydia psittaci and Chlamydia pneumoniae cause community-acquired pneumonias. Doxycycline is the preferred antibiotic for treating all chlamydial infections in nonpregnant adults.
Area of Science:
- Infectious Diseases
- Microbiology
- Pulmonology
Background:
- Chlamydia psittaci and Chlamydia pneumoniae are significant causes of community-acquired pneumonia.
- Chlamydia trachomatis can cause pneumonia in immunocompromised adults and neonates.
- Chlamydia psittaci causes psittacosis, a zoonotic atypical pneumonia.
Purpose of the Study:
- To review the role of Chlamydia species in respiratory infections.
- To discuss the clinical presentations and treatment of chlamydial pneumonias.
- To highlight antibiotic sensitivities and treatment preferences for chlamydial infections.
Main Methods:
- Literature review of Chlamydia species and their association with pneumonia.
- Analysis of clinical presentations of chlamydial pneumonias.
- Evaluation of antibiotic efficacy against different Chlamydia species.
Main Results:
- Chlamydia pneumoniae is increasingly recognized, causing up to 10% of community-acquired pneumonias with symptoms similar to Mycoplasma pneumoniae.
- Chlamydia pneumoniae can lead to other respiratory infections and potentially permanent airway diseases like asthma.
- Doxycycline is effective against all Chlamydia species, while macrolides have limited in vivo activity against C. psittaci and C. pneumoniae.
Conclusions:
- Doxycycline is the preferred antibiotic for treating all chlamydial infections in nonpregnant adults.
- Understanding the spectrum of Chlamydia-related respiratory illnesses is crucial for diagnosis and management.
- Further research may be needed to optimize treatment strategies for C. psittaci and C. pneumoniae infections.
Related Concept Videos
Bacterial Phylum Chlamydiae
Atypical Pneumonia
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Sexually Transmitted Infections
